As of 2024-12-14, the Relative Valuation of AtriCure Inc (ATRC) is (29.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.67 USD, the upside of AtriCure Inc based on Relative Valuation is -191.7%.
The range of the Relative Valuation is (27.65) - (31.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 34.6x - 41.3x | 37.4x |
| Forward P/E multiples | 31.7x - 39.3x | 35.3x |
| Fair Price | (27.65) - (31.41) | (29.04) |
| Upside | -187.3% - -199.2% | -191.7% |
| Date | P/E |
| 2024-12-13 | -39.67 |
| 2024-12-12 | -41.07 |
| 2024-12-11 | -41.72 |
| 2024-12-10 | -42.56 |
| 2024-12-09 | -42.51 |
| 2024-12-06 | -42.90 |
| 2024-12-05 | -42.73 |
| 2024-12-04 | -45.48 |
| 2024-12-03 | -45.24 |
| 2024-12-02 | -46.42 |
| 2024-11-29 | -45.29 |
| 2024-11-27 | -45.31 |
| 2024-11-26 | -44.83 |
| 2024-11-25 | -45.11 |
| 2024-11-22 | -44.76 |
| 2024-11-21 | -44.69 |
| 2024-11-20 | -45.13 |
| 2024-11-19 | -45.52 |
| 2024-11-18 | -43.49 |
| 2024-11-15 | -43.88 |
| 2024-11-14 | -44.23 |
| 2024-11-13 | -45.34 |
| 2024-11-12 | -45.88 |
| 2024-11-11 | -47.85 |
| 2024-11-08 | -46.91 |
| 2024-11-07 | -46.80 |
| 2024-11-06 | -47.12 |
| 2024-11-05 | -44.43 |
| 2024-11-04 | -42.16 |
| 2024-11-01 | -41.97 |
| 2024-10-31 | -41.56 |
| 2024-10-30 | -43.63 |
| 2024-10-29 | -36.86 |
| 2024-10-28 | -36.01 |
| 2024-10-25 | -34.99 |
| 2024-10-24 | -35.92 |
| 2024-10-23 | -36.14 |
| 2024-10-22 | -35.86 |
| 2024-10-21 | -35.75 |
| 2024-10-18 | -36.06 |
| 2024-10-17 | -35.79 |
| 2024-10-16 | -36.53 |
| 2024-10-15 | -35.84 |
| 2024-10-14 | -34.57 |
| 2024-10-11 | -34.87 |
| 2024-10-10 | -33.88 |
| 2024-10-09 | -33.85 |
| 2024-10-08 | -34.22 |
| 2024-10-07 | -33.91 |
| 2024-10-04 | -34.61 |